Ramona Rotolo
Turin, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis.
Journal: Cancer immunology, immunotherapy : CII
Published: September 06, 2024
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade.
Journal: British journal of cancer
Published: February 24, 2023
Integrated Antitumor Activities of Cellular Immunotherapy with CIK Lymphocytes and Interferons against KIT/PDGFRA Wild Type GIST.
Journal: International journal of molecular sciences
Published: July 20, 2022
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriers.
Journal: British journal of haematology
Published: July 01, 2022
Novel Lymphocyte-Independent Antitumor Activity by PD-1 Blocking Antibody against PD-1+ Chemoresistant Lung Cancer Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 13, 2022
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical Perspective.
Journal: Cells
Published: January 22, 2021
CSPG4-Specific CAR.CIK Lymphocytes as a Novel Therapy for the Treatment of Multiple Soft-Tissue Sarcoma Histotypes.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 30, 2020
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive Immunotherapy.
Journal: International journal of molecular sciences
Published: April 18, 2019
CD44v6 as innovative sarcoma target for CAR-redirected CIK cells.
Journal: Oncoimmunology
Published: September 01, 2017
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 Antibody.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 01, 2017
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 21, 2016
Last Updated: 09/26/2026